Heart failure presents a growing public health problem both in Estonia and across Europe. At the same time, ...

At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

At MWC 2026, Huawei released its AIDP. This platform integrates a knowledge base, KV cache acceleration, and a memory bank, and uses the Unified Cache Manager (UCM) to manage and schedule inference ...

The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...

The new eighth‑generation TPUs mark a shift away from one‑size‑fits‑all accelerators, targeting distinct cost, memory, and ...

A WIRED review of permits for data center projects using natural gas and linked to OpenAI, Meta, Microsoft, and xAI shows ...

Google unveiled Deep Research and Deep Research Max, new Gemini 3.1 Pro-powered AI agents that combine web search, ...